What types of chemotherapy are more likely than others to cause anemia?
In particular, platinum-containing chemotherapy, such as cisplatin (Platinol) and carboplatin (Paraplatin), are more likely to cause anemia, though other chemotherapy may cause anemia. Q: What are the situations in which ESAs are not appropriate for use by people with cancer? A: ESAs are not appropriate for people with cancer who are not receiving chemotherapy, and people with blood cancers other than myeloma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia (CLL). People with acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) should not take ESAs. Q: What questions should patients ask their doctors about chemotherapy-related anemia and ESAs? A: Patients should ask their doctors what is the cause of the anemia, what is the best way to treat it, how will the treatment help, and what are the possible risks of the treatment. A complete listing of helpful questions to ask your doctor is available in the What to Know: ASCO’s Guideline on
